Predictors of biologic treatment of psoriasis: a non-interventional study (Q37600690)

21 August 2017

Predictors of biologic treatment of psoriasis: a non-interventional study (English)

1 reference

21 August 2017

Luis Puig

1

1 reference

21 August 2017

Tao Fan

series ordinal

2

1 reference

21 August 2017

Qian Ding

series ordinal

3

1 reference

21 August 2017

Nancy E Smith

series ordinal

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

17 February 2014

1 reference

ClinicoEconomics and Outcomes Research

21 August 2017

1 reference

21 August 2017

6

1 reference

21 August 2017

93-100

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

21 August 2017

start time

1 February 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Definition of treatment goals for moderate to severe psoriasis: a European consensus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Severe Psoriasis – Oral Therapy with a New Retinoid

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Nail psoriasis in Germany: epidemiology and burden of disease

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

The burden of psoriasis and barriers to satisfactory care: results from a Canadian patient survey

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Psoriasis and dyslipidaemia: a population-based study

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Quality of psoriasis care in Germany--results of the national study PsoHealth 2007.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

European S3-Guidelines on the systemic treatment of psoriasis vulgaris

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933358

Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers

3 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24600238

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Psoriasis and hypertension: a case-control study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24600238

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Psoriatic nails: a prospective clinical study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24600238

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/CEOR.S54797

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24600238

1 reference